Treatment for Anxiety

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Brigham and Women's Hospital, Boston, MA
Anxiety+1 More
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This pilot study is a precursor to a subsequent clinical trial that will test the impact of a set of automated motivational messages on patient engagement with a digital mental health intervention. The pilot study aims to systematically employ patient feedback to develop the automated motivational messages that will be used in the subsequent clinical trial.

Eligible Conditions

  • Anxiety

Treatment Effectiveness

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 3 hours from message delivery

Hour 3
Engagement
Message likability ratings
Message motivation ratings

Trial Safety

Trial Design

0 Treatment Group

10 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 hours from message delivery
Closest Location: Brigham and Women's Hospital · Boston, MA
Photo of Boston 1Photo of Boston 2Photo of Boston 3
2008First Recorded Clinical Trial
9 TrialsResearching Anxiety
1051 CompletedClinical Trials

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,453 Previous Clinical Trials
9,701,234 Total Patients Enrolled
11 Trials studying Anxiety
1,234 Patients Enrolled for Anxiety
National Institute of Mental Health (NIMH)NIH
2,490 Previous Clinical Trials
1,766,061 Total Patients Enrolled
61 Trials studying Anxiety
30,823 Patients Enrolled for Anxiety
Jessica M Lipschitz, PhDPrincipal InvestigatorBrigham and Women's Hospital
1 Previous Clinical Trials
76 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You own a smartphone.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.